Clinical Trial Update: Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating suspected liver pathology in patients who cannot receive contrast-enhanced CT or MRI was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Mass
• Liver Metastasis

Snippet

Sponsor: Northeastern Ohio Radiology Research and Education Fund | Conditions: Liver Metastasis, Liver Mass | Phase 3 | Status: WITHDRAWN